Rodón et al. observed that CREB1 could promote a malignant transforming growth factor (TGF) β2 autocrine loop in glioblastoma [24,25], which in turn induced epithelial–mesenchymal transition and endowed cancer cells with metastatic properties [26]. The gene discussed is CREB1; the disease is cancer.